002737 葵花药业
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)5.21624.95821.91620.45818.250
总资产报酬率 ROA (%)3.63816.08713.69313.11311.215
投入资产回报率 ROIC (%)4.95121.73718.55717.90916.241

边际利润分析
销售毛利率 (%)56.76656.29157.74959.26658.137
营业利润率 (%)22.27823.97821.29719.84422.145
息税前利润/营业总收入 (%)21.50723.20621.00219.83021.943
净利润/营业总收入 (%)17.80420.43617.85717.09017.908

收益指标分析
经营活动净收益/利润总额(%)94.74288.88396.07590.94386.493
价值变动净收益/利润总额(%)0.0152.257-0.9172.9471.855
营业外收支净额/利润总额(%)-0.179-0.890-0.3591.0410.027

偿债能力分析
流动比率 (X)3.3553.1502.2352.7092.536
速动比率 (X)2.7552.5761.9442.1422.051
资产负债率 (%)26.15427.27836.87630.16933.688
带息债务/全部投入资本 (%)-3.078-0.50811.1460.508--
股东权益/带息债务 (%)-3,128.883-18,419.112725.12217,605.2896,212.196
股东权益/负债合计 (%)268.635253.749162.156218.190184.620
利息保障倍数 (X)-29.380-41.386-95.903-89.227-105.857

营运能力分析
应收账款周转天数 (天)4.3516.89412.25013.0310.000
存货周转天数 (天)122.249108.747112.202125.9850.000